Biopharma investor relations
Web1 day ago · SEATTLE, Wash., April 12, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that the management team will participate in two upcoming investor … WebApr 12, 2024 · Displaying 1 - 10 of 869 results. Data provided by Kaleidoscope. For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.
Biopharma investor relations
Did you know?
WebMar 16, 2024 · Investor Relations. Arbutus Biopharma Corporation ( NASDAQ:ABUS) is a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to … WebAug 30, 2024 · I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2024. 2024.03.31
http://biopharmacapital.com/ WebMar 1, 2024 · SEATTLE, Feb. 28, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced the U.S. Food and Drug Administration (FDA) has approved VONJO (pacritinib) for the treatment of adults with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis …
WebStatera Biopharma, Inc. (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis. Statera has a large platform of toll-like ... WebThe Investor Relations website contains information about PDL BioPharma, Inc.'s business for stockholders, potential investors, and financial analysts.
WebSep 30, 2024 · INVESTOR RELATIONS KEY FIGURES. Kedrion is a leading biopharmaceutical company that specializes in the development, production and distribution of plasma-derived therapeutic products for use in treating serious diseases, disorders and conditions such as immune system deficiencies and coagulation disorders.
WebMar 23, 2024 · Investors Overview Corporate Profile Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with … lithography maskWeb21 hours ago · Turning to the calls side of the option chain, the call contract at the $9.50 strike price has a current bid of 49 cents. If an investor was to purchase shares of TEVA stock at the current price ... im still a guy by brad paisleyWebPOINT Biopharma is publicly traded on the NASDAQ stock exchange (NASDAQ: PNT) Focus Pipeline + ABOUT OUR PIPELINE. Behind the science. Patients + Caregivers. … lithography market sizeWebThe Investor Relations website contains information about Landos Biopharma's business for stockholders, potential investors, and financial analysts. ... Landos Biopharma is a … lithography materialsWebTheravance Biopharma is a biopharmaceutical company with one approved product that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with … lithography meansWebAug 15, 2024 · The Investor Relations website contains information about Biora Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. lithography medical definitionWeb1 day ago · SEATTLE, Wash., April 12, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that the management team will participate in two upcoming investor … lithography mask polarity